Sanctuary Advisors LLC Acquires 4,738 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Sanctuary Advisors LLC grew its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 29.6% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 20,761 shares of the company’s stock after purchasing an additional 4,738 shares during the quarter. Sanctuary Advisors LLC’s holdings in GE HealthCare Technologies were worth $1,948,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of GEHC. Diamant Asset Management Inc. raised its stake in GE HealthCare Technologies by 4.2% in the third quarter. Diamant Asset Management Inc. now owns 10,257 shares of the company’s stock worth $963,000 after buying an additional 410 shares in the last quarter. Westside Investment Management Inc. raised its position in shares of GE HealthCare Technologies by 32.0% in the 3rd quarter. Westside Investment Management Inc. now owns 516 shares of the company’s stock worth $48,000 after acquiring an additional 125 shares in the last quarter. TCW Group Inc. lifted its stake in shares of GE HealthCare Technologies by 6.8% during the 3rd quarter. TCW Group Inc. now owns 533,352 shares of the company’s stock worth $50,055,000 after purchasing an additional 33,937 shares during the last quarter. Soltis Investment Advisors LLC bought a new stake in GE HealthCare Technologies during the third quarter valued at about $206,000. Finally, TD Private Client Wealth LLC grew its stake in GE HealthCare Technologies by 213.8% in the third quarter. TD Private Client Wealth LLC now owns 11,478 shares of the company’s stock valued at $1,077,000 after purchasing an additional 7,820 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Insider Transactions at GE HealthCare Technologies

In related news, CEO Roland Rott sold 3,577 shares of the company’s stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $86.48, for a total transaction of $309,338.96. Following the completion of the transaction, the chief executive officer now owns 24,298 shares in the company, valued at $2,101,291.04. This represents a 12.83 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 0.27% of the company’s stock.

Analysts Set New Price Targets

GEHC has been the subject of a number of analyst reports. Stifel Nicolaus increased their target price on shares of GE HealthCare Technologies from $100.00 to $102.00 and gave the company a “buy” rating in a research report on Monday, September 30th. Evercore ISI boosted their target price on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 1st. BTIG Research raised GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 target price on the stock in a research report on Wednesday, September 18th. JPMorgan Chase & Co. began coverage on GE HealthCare Technologies in a research note on Monday, September 9th. They issued a “neutral” rating and a $90.00 price objective for the company. Finally, UBS Group lowered GE HealthCare Technologies from a “neutral” rating to a “sell” rating and dropped their target price for the company from $84.00 to $74.00 in a research report on Thursday, September 26th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $95.46.

GE HealthCare Technologies Price Performance

NASDAQ:GEHC opened at $77.09 on Thursday. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.23 and a quick ratio of 0.98. The company has a 50 day moving average price of $85.14 and a 200-day moving average price of $83.75. GE HealthCare Technologies Inc. has a 1-year low of $71.31 and a 1-year high of $94.55. The firm has a market cap of $35.22 billion, a price-to-earnings ratio of 21.18, a price-to-earnings-growth ratio of 2.96 and a beta of 1.07.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $1.14 earnings per share for the quarter, topping analysts’ consensus estimates of $1.06 by $0.08. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. The business had revenue of $4.86 billion during the quarter, compared to the consensus estimate of $4.87 billion. During the same quarter in the prior year, the firm posted $0.99 earnings per share. The company’s revenue was up .9% compared to the same quarter last year. Equities research analysts forecast that GE HealthCare Technologies Inc. will post 4.3 EPS for the current year.

GE HealthCare Technologies Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 14th will be given a $0.035 dividend. The ex-dividend date of this dividend is Tuesday, January 14th. This is a boost from GE HealthCare Technologies’s previous quarterly dividend of $0.03. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.18%. GE HealthCare Technologies’s payout ratio is 3.85%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.